330 related articles for article (PubMed ID: 11657653)
1. Ethics and AIDS drugs: some countries want to suspend patent and trade laws to get lower-cost medications to the poor.
Dowell W
Time; 1999 Jul; 152(4):49. PubMed ID: 11657653
[No Abstract] [Full Text] [Related]
2. Cost of HIV drugs.
American Public Health Association
Am J Public Health; 1991 Feb; 81(2):250. PubMed ID: 11642863
[No Abstract] [Full Text] [Related]
3. The exclusion from the United States of aliens infected with the AIDS virus: recent developments and prospects for the future.
Osuna JP
Houst J Int Law; 1993; 16(1):1-41. PubMed ID: 11652756
[No Abstract] [Full Text] [Related]
4. AIDS conference confused over Thai trial.
New Sci; 1992 Sep; 135(1838):7. PubMed ID: 11656156
[No Abstract] [Full Text] [Related]
5. International travel restrictions and the AIDS epidemic.
Nelson LJ
Am J Int Law; 1987 Jan; 81(1):230-6. PubMed ID: 11649887
[No Abstract] [Full Text] [Related]
6. RU 486 and the politics of drug regulation in the United States and France.
Kramnick RK
Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
[No Abstract] [Full Text] [Related]
7. Access to AIDS treatment in developing countries: a global issue of equity and human rights.
Thomas J
AIDS Anal Asia; 1998 Mar; 4(2):2-4. PubMed ID: 11657713
[No Abstract] [Full Text] [Related]
8. Clinical AIDS research that evaluates cost effectiveness in the developing world.
Christakis NA; Lynn LA; Castelo A
IRB; 1991; 13(4):6-8. PubMed ID: 11651482
[No Abstract] [Full Text] [Related]
9. Blood money.
Hunter M
Discover; 1993 Aug; 14(8):70-8. PubMed ID: 11654912
[No Abstract] [Full Text] [Related]
10. Ethics and AIDS drugs.
Dowell W
Time; 1999 Jul; 154(2):49. PubMed ID: 10538646
[No Abstract] [Full Text] [Related]
11. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
Ghosh S
Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
[No Abstract] [Full Text] [Related]
12. Global patent police block cost-reduction efforts.
Kasper T
GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
[TBL] [Abstract][Full Text] [Related]
13. Controversial AIDS vaccine to be tested in China.
Brown P
New Sci; 1993 May; 138(1875):7. PubMed ID: 11656245
[No Abstract] [Full Text] [Related]
14. Patents, but no cure.
Schweiger T
Splice Life; 1998; 4(5):12-3. PubMed ID: 11657659
[No Abstract] [Full Text] [Related]
15. Ethical dilemmas with studies in less-developed countries: AIDS research trials.
Barry M
IRB; 1991; 13(4):8-9. PubMed ID: 11651483
[No Abstract] [Full Text] [Related]
16. Patients v. patents?: policy implications of recent patent legislation.
Katopis CJ
St Johns Law Rev; 1997; 71():329-401. PubMed ID: 11658166
[No Abstract] [Full Text] [Related]
17. How the West gets well.
Day M
New Sci; 1997 May; 154(2082):14-5. PubMed ID: 11656795
[No Abstract] [Full Text] [Related]
18. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
19. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
20. Access to essential drugs.
Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
